Patent · US Active

Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis

US7935786B2 · kind B2 · utility

47Cited by

34References

26Claims

0Family size

Assignee

Zealand Pharma A/S · DK

Inventor

Bjarne Due Larsen · Roskilde, DK

Key dates

Filing date	May 25, 2007
Grant date	May 3, 2011
Priority date	—
Expiry date	May 25, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/31
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention is directed to a pharmacologically active peptide conjugate having a reduced tendency towards enzymatic cleavage comprising a pharmacologically active peptide sequence (X) and a stabilising peptide sequence (Z) of 4-20 amino acid residues covalently bound to X.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.